Ovizio Imaging Systems and Applikon Biotechnology jointly announce today the signing of a long term worldwide marketing and distribution agreement for an innovative device using a proprietary imaging technology in microscopy.

Applikon will market worldwide an innovative and integrated solution, developed by Ovizio, that combines 4D microscopic imaging with the Applikon bioreactor systems. This new device will offer automated on-line information on cell density, cell viability and morphologic state of the cells.

Applikon and Ovizio have a common vision of the potential of optical image analysis in bioprocessing said Erik Kakes, commercial director of Applikon Biotechnology. "We feel that using optical 4D image analysis for determination of biomass concentration and viability is only the first step in applying this revolutionary technology to the bioprocess industry", he added.

We are absolutely delighted to partner with a company having such an in-depth knowledge of the market and strong reputation within the Bioprocess industry, said Philip Mathuis, CEO of Ovizio. We believe that quantitative imaging as a new Process Analytical Technology (PAT) applied to on-line bioreactor monitoring will allow Biopharma customers to improve process knowledge, quality and productivity in their R&D, Pilot and Production environments.

The new device will be jointly presented at the next Het Instrument Amsterdam, exhibition on 26 September 2012.

About Ovizio Imaging Systems NV/SA Ovizio is a spin-off company of the Universit Libre de Bruxelles (ULB). The company designs, develops and markets 4-D quantitative imaging systems and sensors based on patented Digital Holographic Microscopy with a primary focus on the Life Science Research, Biotechnology and Bioprocessing industry..

Ovizios platform technology unifies real-time quantitative imaging with speed and a label-free, non-invasive approach. Our advanced devices generate high quality holographic images ideal for studying dynamic phenomena, breaking the barriers between the traditional speed of flow cytometry and the resolution of classical microscopy.

Ovizio is a privately held company situated in Brussels, Belgium. For more information, visit http://www.ovizio.com.

SOURCE: Applikon Biotechnology

See the original post:
Ovizio And Applikon Biotechnology Sign Long Term Marketing And Distribution Agreement